| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Sep'18 | Jun'18 |
|---|---|---|---|---|---|---|
Collaboration revenue | ||||||
5,594 | -333 | 5,675 | 5,567 | 6,068 | - | - |
Operating expenses: | ||||||
Research and development | ||||||
18,960 | 16,820 | 12,635 | 13,907 | 10,370 | 5,767 | 5,293 |
General and administrative | ||||||
4,423 | 3,426 | 2,898 | 2,077 | 1,832 | 1,405 | 972 |
Total operating expenses | ||||||
23,383 | 20,246 | 15,533 | 15,984 | 12,202 | 7,172 | 6,265 |
Loss from operations | ||||||
-17,789 | -20,579 | -9,858 | -10,417 | -6,134 | -7,172 | -6,265 |
Other income: | ||||||
Interest income, net | ||||||
886 | 1,092 | 1,392 | 1,119 | 1,063 | 111 | 34 |
Other expense, net | ||||||
- | - | 94 | - | - | 16 | - |
Total other income, net | ||||||
886 | 1,092 | 1,298 | 1,119 | 1,063 | 95 | 34 |
Loss before benefit from (provision for) income taxes | ||||||
-16,903 | -19,487 | -8,560 | -9,298 | -5,071 | -7,077 | -6,231 |
Benefit from (provision for) income taxes | ||||||
-157 | 344 | 304 | 135 | 129 | 0 | 0 |
Net loss | ||||||
-16,746 | -19,831 | -8,864 | -9,433 | -5,200 | -7,077 | -6,231 |
Net loss per share, basic and diluted | ||||||
-0.55 | 5.11 | -0.30 | -4.73 | -2.77 | -7.00 | -6.16 |
Weighted average common shares outstanding, basic and diluted | ||||||
30,188 | 30,536 | 29,999 | 1,992 | 1,879 | 1,011 | 1,011 |
Comprehensive loss: | ||||||
Net loss | ||||||
-16,746 | - | - | - | -5,200 | - | - |
Other comprehensive income: | ||||||
Unrealized holding gains on marketable securities | ||||||
571 | -3 | 6 | 16 | 25 | - | - |
Total other comprehensive income | ||||||
571 | - | - | - | 25 | - | - |
Comprehensive loss | ||||||
-16,175 | -19,834 | -8,858 | -9,417 | -5,175 | -7,077 | -6,231 |
AbbVie | ||||||
Collaboration revenue | ||||||
3,392 | - | - | - | 5,570 | - | - |
Janssen | ||||||
Collaboration revenue | ||||||
2,202 | - | - | - | 498 | - | - |
Collaboration revenue - related party | ||||||
Collaboration revenue | ||||||
- | - | 3,772 | 4,395 | - | - | - |
Collaboration revenue - other | ||||||
Collaboration revenue | ||||||
- | - | 1,903 | 1,172 | - | - | - |